Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: Morphological and behavioral outcomes

Behavioural Brain Research

Volumn 217, Issue 2, 2011, Pages 369-378

  Rossignol, Julien ^a,b,c,d,e   Boyer, Cécile ^a,b,c   Lévèque, Xavier ^a,b,c   Fink, Kyle D ^d   Thinard, Reynald ^a,b,c   Blanchard, Frédéric ^c,f   Dunbar, Gary L ^d,e   Lescaudron, Laurent ^a,b,c  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d CENTRAL MICHIGAN UNIVERSITY   (United States)

^e Field Neurosciences Institute   (United States)

^f Universite de Nantes   (France)

Author keywords

3NP intoxication; DMEM; Huntington's disease; Mesenchymal stem cells; Transplantation; Trophic factors

Indexed keywords

3 NITROPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; COLLAGEN TYPE 1; FIBRONECTIN; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE DILATATION; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; LATERAL BRAIN VENTRICLE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; CONVULSANTS; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GENE EXPRESSION REGULATION; HINDLIMB; HUNTINGTON DISEASE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR ACTIVITY; NERVE GROWTH FACTORS; NITRO COMPOUNDS; OSTEOBLASTS; PHOSPHOPYRUVATE HYDRATASE; PROPIONIC ACIDS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

EID: 78650416363     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.11.006     Document Type: Article

References (54)

1. Martin J.B., Gusella J.F. Huntington's disease. Pathogenesis and management. N Engl J Med 1986, 315:1267-1276.
2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72:971-983.
3. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003, 60:1615-1620.
4. Dunnett S.B., Rosser A.E. Cell therapy in Huntington's disease. NeuroRx 2004, 1:394-405.
5. Bjorklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000, 3:537-544.
6. Nakao N., Itakura T. Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog Neurobiol 2000, 61:313-338.
7. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., et al. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 1998, 154:31-40.
8. Bachoud-Levi A.C., Remy P., Nguyen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
9. Bachoud-Levi A.C., Gaura V., Brugieres P., Lefaucheur J.P., Boisse M.F., Maison P., et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006, 5:303-309.
10. Svendsen C. Adult versus embryonic stem cells: which is the way forward?. Trends Neurosci 2000, 23:450.
11. Lescaudron L., Unni D., Dunbar G.L. Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: behavioral and morphological outcomes. Int J Neurosci 2003, 113:945-956.
12. Dunbar G.L., Sandstrom M.I., Rossignol J., Lescaudron L. Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev 2006, 5:63-79.
13. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
14. Dunbar G.L., Oh-Lee J., Lescaudron L. Use of bone marrow stem cells as therapy for behavioral deficits in rodent models of Huntington's disease. Contemporary neuroscience: cell therapy for brain repair 2005, 117-138. Humana Press Inc., Totowa, NJ, USA. C.D. Davis, P.R. Sanberg (Eds.).
15. Hickey M.A., Chesselet M.F. Apoptosis in Huntington's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:255-265.
16. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
17. Rossignol J., Boyer C., Thinard R., Remy S., Dugast A.S., Dubayle D., et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009.
18. Alston T.A., Mela L., Bright H.J. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 1977, 74:3767-3771.
19. Canals J.M., Pineda J.R., Torres-Peraza J.F., Bosch M., Martin-Ibanez R., Munoz M.T., et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 2004, 24:7727-7739.
20. Brouillet E., Hantraye P. Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Curr Opin Neurol 1995, 8:469-473.
21. Shear D.A., Haik K.L., Dunbar G.L. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 2000, 11:1833-1837.
22. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 2005, 95:1521-1540.
23. Bemelmans A.P., Horellou P., Pradier L., Brunet I., Colin P., Mallet J. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 1999, 10:2987-2997.
24. Perez-Navarro E., Canudas A.M., Akerund P., Alberch J., Arenas E. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J Neurochem 2000, 75:2190-2199.
25. Dey N.D., Bombard M.C., Roland B.P., Davidson S., Lu M., Rossignol J., et al. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 2005, 214:193-200.
26. Azizi S.A., Stokes D., Augelli B.J., DiGirolamo C., Prockop D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998, 95:3908-3913.
27. Chipoy C., Berreur M., Couillaud S., Pradal G., Vallette F., Colombeix C., et al. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J Bone Miner Res 2004, 19:1850-1861.
28. Bessman S.P., Carpenter C.L. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem 1985, 54:831-862.
29. Bures J., Buresova O., Krivanek J. Brain and behavior: paradigms for research in neural mechanisms 1988, Wiley, Chichester, UK.
30. Olsson M., Nikkhah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995, 15:3863-3875.
31. Winkler C., Kirik D., Bjorklund A., Cenci M.A. l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 2002, 10:165-186.
32. Paille V., Henry V., Lescaudron L., Brachet P., Damier P. Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias. Mov Disord 2007, 22:533-539.
33. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
34. Michel D.C., Nerriere-Daguin V., Josien R., Brachet P., Naveilhan P., Neveu I. Dendritic cell recruitment following xenografting of pig fetal mesencephalic cells into the rat brain. Exp Neurol 2006, 202:76-84.
35. Lescaudron L., Sutton R.L., Stein D.G. Effects of fetal forebrain transplants in ibotenic-injured nucleus basalis: an anatomical investigation. Int J Neurosci 1993, 69:97-104.
36. Mittoux V., Ouary S., Monville C., Lisovoski F., Poyot T., Conde F., et al. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. J Neurosci 2002, 22:4478-4486.
37. Cowan C.M., Raymond L.A. Selective neuronal degeneration in Huntington's disease. Curr Top Dev Biol 2006, 75:25-71.
38. Escartin C., Boyer F., Bemelmans A.P., Hantraye P., Brouillet E. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Neurosci Lett 2007, 425:167-172.
39. Dey N.D., Boersen A.J., Myers R.A., York L.R., Bombard M.C., Lu M., et al. The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease. Restor Neurol Neurosci 2007, 25:485-492.
40. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kuemmerle S., Kubilus J.K., et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 2000, 20:4389-4397.
41. Chou S.Y., Lee Y.C., Chen H.M., Chiang M.C., Lai H.L., Chang H.H., et al. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J Neurochem 2005, 93:310-320.
42. Puri B.K., Bydder G.M., Manku M.S., Clarke A., Waldman A.D., Beckmann C.F. Reduction in cerebral atrophy associated with ethyl-eicosapentaenoic acid treatment in patients with Huntington's disease. J Int Med Res 2008, 36:896-905.
43. Ventimiglia R., Mather P.E., Jones B.E., Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995, 7:213-222.
44. Ivkovic S., Ehrlich M.E. Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 1999, 19:5409-5419.
45. Weimar I.S., Voermans C., Bourhis J.H., Miranda N., van den Berk P.C., Nakamura T., et al. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells. Leukemia 1998, 12:1195-1203.
46. Markiewicz I., Lukomska B. The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol Exp (Wars) 2006, 66:343-358.
47. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19:331-338.
48. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999, 96:10711-10716.
49. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000, 11:3001-3005.
50. Mahmood A., Lu D., Yi L., Chen J.L., Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg 2001, 94:589-595.
51. Sabel B.A., Labbe R., Stein D.G. The saline effect: minimizing the severity of brain damage by reduction of secondary degeneration. Exp Neurol 1985, 88:95-107.
52. Moreno-Cuevas J.E., Sirbasku D.A. Estrogen mitogenic action. III. is phenol red a " red herring" ?. In Vitro Cell Dev Biol Anim 2000, 36:447-464.
53. Scharfman H.E., MacLusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 2006, 27:415-435.
54. Geng M.Y., Saito H., Katsuki H. Effects of vitamin B6 and its related compounds on survival of cultured brain neurons. Neurosci Res 1995, 24:61-65.